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In this work, direct and indirect methods for determination of vitamin K 3 were developed using diﬀerential pulse polarography. The reaction between sulﬁte and the quinone (Q) form of vitamin K 3 was used
for indirect determination, since the sulﬁte peak at -0.7 V is sharp and very reproducible in 0.1 M HAc
NaAc (pH = 5.5). It was found that at pH 4.5-5.5, this reaction was quantitative and very fast when the
temperature was 45

◦

C. For its direct determination, on the other hand, vitamin K 3 was standardized by

the indirect method using standard sulﬁte as the reducing agent. The calibration graph for vitamin K 3 (in
Q form), using the peak at -1.0 V in a HAc-NaAc medium with a pH of 5.5, was linear for concentrations
ranging from 5 × 10 −7 to 3 × 10 −5 M, and the limit of detection (LOD) was 1.5 × 10 −7 M. The proposed
methods were successfully applied to the determination of vitamin K 3 in a clinical injection solution and in
blood serum.
Key Words: Vitamin K 3 , sulﬁte, direct, indirect, diﬀerential pulse polarography

Introduction
Vitamins are important organic compounds for biological activities. Deﬁciencies in several vitamins are risk
factors for chronic diseases such as cardiovascular disease, cancer, and osteoporosis 1 . They can be divided into
2 categories according to their solubility in water or fat. Water-soluble vitamins are vitamin C and several
varieties of vitamin B. The fat-soluble vitamins are K, D, E, and A.
∗ Corresponding

author
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Vitamin K plays an important role in blood coagulation and in the bone mineralization process. 2−5 It
also may play a variety of health-promoting roles. Vitamin K reduces the risk of heart disease, kills cancer cells,
and enhances skin health, and may have antioxidant properties. As can be seen, determination of trace vitamin
K has vital importance.
Vitamin K 3 contains a naphthoquinone ring, and its basic structure is 2-methyl-1,4-naphthoquinone.
These vitamins are named according to their side chains by forming new derivatives. Vitamin K 3 is obtained synthetically without a side chain and is named as menadione. Menadione (vitamin K 3 , 2-methyl-1,4naphthoquinone) is a synthetic vitamin K analog, which has been used chieﬂy as an antihemorrhagic agent. 6
There are 2 versions of water soluble vitamin K 3 ; one is menadione sodium bisulﬁte and the other is menadiol
sodium diphosphate. The physiological activity of menadione is the strongest among the K group vitamins. It
shows antitumor and antiinﬂammatory activity because of the quinone group in its structure. In a series of in
vitro and in vivo animal studies, menadione (vitamin K 3 ) showed signiﬁcant antineoplastic activities against
both malignant cell lines and a variety of human tumor cells. 7
There are several methods for the separation and determination of vitamin K 3 . For the clinical tests,
sensitive and rapid analytical methods are needed. The common methods for determination of vitamin K analogs
include spectrophotometric, 8−12 chromatographic, 13−15 and spectroscopic 16 methods, which are frequently
used but have lower sensitivity when compared with polarographic methods.
Cloud point extraction has been used for the preconcentration of vitamin K 3 and 1,4-naphthoquinone
after their reaction by aniline. Preconcentration of 15 mL of sample solution permitted the detection of 0.05
and 0.08 μg mL −1 for vitamin K 3 and 1,4-naphthoquinone, respectively. 11
Vitamin K derivatives (vitamin K 1 , phylloquinone, menaquinones) were determined with the HPLC
ﬂuorescence determination method using post-column reduction and internal standards. 13 Vitamin K 3 was
extracted from the plasma samples with n-hexane, and it was determined by reverse-phase high performance
liquid chromatography. The recovery was 82.4 ± 7.69% (n = 7). 15
As compared with the generally used chromatographic and spectrophotometric methods, the polarographic method has inherent advantages concerning speed, simplicity, and sensibility. Determination of vitamin
K 3 has also been made using electrochemical methods such as voltammetry 17,18 and polarography. 19−23 A
cathodic stripping procedure was described for determination of vitamin K 3 using sodium sulfate as the supporting electrolyte at pH 1.70-1.85. 17 Square wave adsorptive anodic stripping voltammetry was used in a
HClO 4 medium and, with 10 min of deposition time, a detection limit of 1.3 × 10 −10 M was achieved. 18 A
catalytic wave for menadione determination has been proposed in 0.2 M HAc-NaAc (pH = 4.7) electrolyte in
the presence of 4 × 10 −3 M KIO 3 , and a limit of detection (LOD) of 2 × 10 −9 M was obtained. 19 In one
work, menadione was determined using diﬀerential pulse polarography (DPP) in a methyl alcohol medium using
0.2 M borate buﬀer (pH = 6.8) with a LOD of 5 × 10 −7 M. 21
In our former studies, 22 direct and indirect methods were developed in which the reaction between
vitamin K 3 and Ti(III) was used. After reaction between Ti(III) and vitamin K 3 , the quantity of Ti(IV)
formed was determined by standard addition and, from stoichiometric relations, vitamin K 3 content could be
calculated. In both methods, the LOD was found to be 7 × 10 −7 M. These methods can be applied for human
ﬂuids without any extraction or preconcentration procedure.
Electrochemical methods oﬀer useful alternatives since they allow faster, cheaper, and safer analysis.
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The results obtained with the DPP method are very reproducible, since with the use of a dropping mercury
electrode, the behavior of the electrode is independent of its past history. 23,24
All of these methods need reference standard solutions. However, since the solutions on the market are
only 95%-98% pure and very expensive, a standard solution of vitamin has to be prepared using an indirect
method. In nearly no investigations mentioned above was this fact taken into account.
The purpose of this investigation was to establish a simple polarographic method for the determination of
vitamin K 3 indirectly so that standard solutions could be prepared, which would enable direct determination of
the vitamin. For this purpose, the quantitative reaction between sulﬁte and vitamin K 3 was used. Direct and
indirect polarographic methods were developed, whereby it was possible to determine very low concentrations
of vitamin K 3 . These methods were used for the determination of vitamin K 3 contents in clinical injection
solutions and in serum. The results indicate that both of these methods can be used safely for its determination.

Experimental
Apparatus
A polarographic analyzer (PAR 174 A) equipped with a PAR mercury drop timer was used. The drop time
of the electrode was in the range of 2-3 s (2.3 mg s −1 ). A Kalousek electrolytic cell with a saturated calomel
electrode (SCE), separated by a liquid junction, was used in the 3-electrode conﬁguration. All potentials in the
manuscript are given versus SCE. The counter electrode was platinum wire. The polarograms were recorded
with a Linseis (LY 1600) X-Y recorder under the conditions of a drop life of 1 s, a scan rate of 2-5 mV s −1 ,
and a pulse amplitude of 50 mV.

Reagents
All of the chemicals used were of analytical-reagent grade (proanalysis). Triply distilled water was used in the
preparation of all solutions. Solutions of 10 −3 M and more diluted ones were prepared before every use in order
to avoid the aging process of the solution.
By adding 6 g of NaOH washed with distilled water, in order to remove the carbonate formed, to 57 mL
of HAc and diluting the mixture to 1 L, 1 M HAc/Ac buﬀer was prepared.
The mercury used in the dropping mercury electrode was obtained from Merck (Darmstadt, Germany).
Contaminated mercury was cleaned by passing it successively through dilute HNO 3 (3.0 M) and water columns
in the form of ﬁne droplets by using a platinum sieve. The collected mercury was dried between sheets of ﬁlter
paper. Before use, a diﬀerential pulse (DP) polarogram of this mercury was recorded in order to conﬁrm the
absence of impurities.
Preparation of 10 −3 M vitamin K 3 solution
Vitamin K 3 (276.24 g mol −1 ) (menadione sodium bisulﬁte) was obtained from Libavit K. It contains, in each
2-mL vial, 0.02 g (about 0.036 M) of menadione sodium bisulﬁte, 0.006 g of potassium metabisulﬁte (K 2 O 5 S 2 ),
0.0126 g of sodium chloride, and 2 mL of water. For the preparation of a 10 −3 M vitamin K 3 solution, 0.28 mL
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from the clinical injection solution was taken and diluted with distilled water into 10 mL. 22 Air or oxygen gas
was passed for about 20 min to oxidize all of the vitamin and the sulﬁte present (see section 3.2.). Nitrogen gas
was then passed to purge the oxygen from the solution. This procedure was repeated for each solution before
use.

Preparation of 0.1 M standard thiosulfate solution
In 1 L of distilled water, 26.8 g of Na 2 S 2 O 3 was dissolved. For its standardization, KIO 3 had to be used. The
primary standard of KIO 3 (0.64 g) was dissolved in a 250-mL ﬂask with distilled water, 50 mL of it was taken,
and 2 g of KI and 10 mL of 1.0 M HCl were added and titrated with the thiosulfate solution until the color of
the solution became light yellow. Then 3 mL of freshly prepared starch was added, and the titration was ended
when the solution was colorless.

Preparation of iodine solution and standardization
In 20 mL of distilled water, 20 g of KI and 6.7 g of I 2 were dissolved and then diluted to 500 mL. From the
dilution, 25 mL was taken and titrated with standardized thiosulfate solution in the presence of starch.

Preparation of 0.2 M sulﬁte solution and standardization
In 50 mL of deaerated distilled water, 1.26 g of oven-dried Na 2 SO 3 was dissolved.

To protect it from

air oxidation and to reduce the sulfate present, mercury amalgamated zinc granules were added. For the
standardization of the solution, 50.0 mL of 0.048 M I 2 , 2.3 mL of HCl, and 10.0 mL of Na 2 SO 3 solutions were
mixed; the iodine used by sulﬁte was determined by titrating the excess iodine with standardized thiosulfate in
the presence of starch. This solution was standardized after certain periods, when the zinc peak from the Jones
reductor appeared in the polarogram.

Preparation of standard vitamin K 3 solution
A 10 mL solution of approximately 10 −3 M vitamin K 3 , in hydroquinone (H 2 Q) form (from Libavit K), was
prepared. Oxygen was passed for about 20 min to oxidize it into quinone (Q) form. The oxidation may be
controlled by taking DC polarograms (see section 3.1.). Nitrogen was passed for about 20 min to expel oxygen.
A known portion was added to 10 mL of acetate buﬀer (pH = 5.5) for a concentration of about 10 −5 M. To this
solution, a known amount (more than 2.5 times the amount of vitamin) of standardized sulﬁte was added and
then warmed up to 45 ◦ C. After it cooled down, it was taken into a polarographic cell and its DP polarogram
was taken. The peak height of sulﬁte was measured at -0.7 V. The quantity of sulﬁte, which remained after the
reaction with vitamin K 3 , was determined by additions of standard sulﬁte. To determine the quantity of the
sulﬁte reacted, the remaining sulﬁte had to be subtracted from the sulﬁte added at the beginning. This number
was equal to the vitamin K 3 quantity.
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Preparation of Jones reductor
About 50 g of zinc granules were ﬁrst cleaned in 1 M HCl, and then they were left in 0.25 M Hg(NO 3 )2 for
about 2-3 min so that they were amalgamated with mercury. 25 This amalgam was used for the reduction of
CrCl 3 into CrCl 2 , for the elimination of trace oxygen in nitrogen. It was also used to protect the sulﬁte solution
from air oxidation.
Procedure for indirect determination of vitamin K 3
Through an unknown sample of vitamin K 3 , oxygen was passed for about 20 min in order to oxidize both
vitamin K 3 (if in hydroquinone form, H 2 Q) and sulﬁte. Excess sulﬁte was then added and warmed to 45 ◦ C.
A certain amount of it was added to a polarographic cell containing acetate buﬀer (pH = 4.5-5.5) and a known
amount of sulﬁte. The peak height was measured, and standard sulﬁte was added. From the peak height of
sulﬁte, the vitamin K 3 content was calculated.

Results and discussion
Electrochemical behavior of vitamin K 3
As given in the experimental section, vitamin K 3 , in clinical injection solution, contains potassium metabisulﬁte
K 2 S 5 O 2 . This enables the vitamin to be kept in a reduced and water-soluble form, and thus it is possible to
obtain concentrated solutions of the vitamin. With the addition of sulﬁte, the quinone (Q) form turns into the
hydroquinone (H 2 Q) form, as given in Eq. (1). To protect it from air oxidation in the quinone form, sulﬁte has
to be added in excess.
OH

O
-

SO 3 Na

SO 3 -Na +

+

+ SO 42- + 2H +

+ H2SO 3 + H2O
CH3

CH3
O

Q

OH

H2Q

(1)

For polarographic determination, the peaks must ﬁrst be identiﬁed. For this purpose, 1 × 10 −3 M
solution was prepared from the Libavit K in H 2 Q form, containing sulﬁte in excess (see section 2.2.1.). In
acetate buﬀer (pH = 4.5-5.5), its DP polarogram was taken and 4 peaks were observed (Figure 1). The ﬁrst
one, at -0.67 V, belonged to sulﬁte, 26 and the others, at -1.0, -1.2, and -1.45 V, belonged to H 2 Q. The peak at
about -1.0 V was used throughout the work.
As is known, the nature (cathodic or anodic) of a polarographic peak cannot be evaluated by DPP. For
this purpose, direct current (DC) polarography has to be used. The DC polarographic wave for 2 × 10 −4
M vitamin K 3 (H 2 Q, hydroquinone), taken in the positive direction, had an oxidation wave with a half-wave
potential of E 1/2 = -0.94 V in an acetate buﬀer with a pH of 5.5 (Figure 2). The DC polarogram of Q, on the
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other hand, had a cathodic wave with a half-wave potential of E 1/2 = -0.94 V, indicating that the oxidation of
vitamin K 3 was reversible 27 (Figure 3). Using these polarograms, it is possible to follow the presence of Q and
H 2 Q individually in solution.
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Figure 1. Electrochemical behavior of Libavit K, a) pH

Figure 2. DC polarogram of vitamin K 3 (H 2 Q, hydro-

= 5.5, 10 mL HAc-NaAc, b) a + 0.1 mL 1 × 10 −3 M

quinone), a) pH = 5.5, 10 mL HAc-NaAc + 2 × 10 −4 M

vitamin K 3 (H 2 Q), c) b + 0.1 mL 1 × 10 −3 M vitamin

vitamin K 3 (H 2 Q, hydroquinone), b) a + 2 × 10 −4 M

K 3 , d) c + 0.1 mL 1 × 10 −3 M vitamin K 3 .

vitamin K 3 (H 2 Q).

Optimum conditions for the oxidation of vitamin K 3
The purity of vitamins found on the market is about 95%-98%, and it is not possible to prepare a standard
solution. A standard solution of vitamin K 3 can be prepared using the quantitative reaction between standard
sulﬁte and vitamin K 3 (in quinone form, Q). For this purpose, vitamin K 3 has to be in its oxidized form. As
given before, vitamin K 3 was in H 2 Q form in a vial (Libavit K); thus, it had to be oxidized into its quinone
form. Sulﬁte in a vial also has to be oxidized, or otherwise it may create problems as a reducing agent. Since
the standard reduction potential of sulfate is E 0 = 0.172 V, the reduction potential of Q is E 0 = 0.7 V, and
that of oxygen is E 0 = 1.23 V, oxygen can be used for their oxidation quantitatively (Eqs. (2) and (3)). Oxygen
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gas has been used for the oxidation of both sulﬁte and vitamin K 3 in H 2 Q form.
O2(g) + 2H2 Q ↔ 2H2 O + 2QΔE = 0.53V

(2)

O2(g) + 2H2SO3 ↔ 2SO42− + 4H + ΔE = 1.06V

(3)

c

b

.
Ic
0
.
Ia

a

0.0

-0.2

-0.4 -0.6 -0.8 -1.0

-1.2

-1.4

E(V) vs.SCE

Figure 3. DC polarogram of vitamin K 3 (Q form). a) pH = 5.5, 10 mL HAc-NaAc, b) a + 5 × 10 −5 M vitamin K 3
(Q), c) b + 5 × 10 −5 M vitamin K 3 (Q).

To estimate the oxygen gas passing period for the conversion to be complete, 5, 10, 15, 20, or 30 min of
passing time were tested in a solution containing 10 mL of 1 × 10 −3 M vitamin K 3 . After each period of time,
a DP polarogram was taken in acetate buﬀer (pH = 4.5-5.5) to observe whether sulﬁte (from its -0.67 V peak),
which was present in the vial, was still present (nitrogen gas was passed before each experiment). It was found
that sulﬁte was completely oxidized when oxygen was passed for 10 min. To follow the oxidation of vitamin K 3 ,
a DC polarogram (see section 3.1.) of this solution was taken in the positive direction. It was found that some
H 2 Q was still present after 10 and 15 min of oxygen passing time, but after 20 and 30 min of oxygen passing
time, no oxidation wave (DC) for vitamin K 3 was observed, indicating that all H 2 Q was oxidized. Thus, it was
decided to pass oxygen for about 20 min throughout the work.

Optimum conditions for the reaction between sulﬁte and vitamin K 3
Vitamin K 3 in an unknown sample can be determined by direct and indirect methods. As is known, it is not
possible to ﬁnd a standard solution of this vitamin. Therefore, an indirect method, in which a substance reacts
with the vitamin quantitatively, has to be provided. After it is standardized, this solution can be used for direct
determination safely. Although the standardization will take a longer time, after it is standardized, the vitamin
K 3 content of an unknown sample can be determined in a very short time directly by standard additions, and
it may be applied for routine analysis. Since the standard reduction potential of sulfate is E 0 = 0.172 V and
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the reduction potential of Q is E 0 = 0.7 V, the reaction between sulﬁte and vitamin K 3 should be quantitative.
By following the peak of sulﬁte in DPP polarograms, it was shown that vitamin K 3 was reduced by sulﬁte.
According to Eq. (1), 1 mol of vitamin K 3 uses 1 mol of sulﬁte.
To ﬁnd the optimum conditions, the reaction had to be followed under various conditions. For this
purpose, DP polarograms of vitamin K 3 containing sulﬁte were taken in varying concentrations (4, 3, 2, 1,
and 0.1 M) of HCl. It was observed that in these acidic solutions, SO 2 was escaping, 22,26,28 and thus indirect
determination of vitamin K 3 with sulﬁte was not possible in acidic solutions. After testing various electrolytes,
it was found that the best medium for the indirect determination of vitamin K 3 was acetate buﬀer (pH =
4.5-5.5). At higher pH values, the reaction between vitamin and sulﬁte was not quantitative.
To follow the reaction between sulﬁte and vitamin K 3 , 3.2 × 10 −7 M vitamin K 3 (in Q form) and 8.4 ×
10 −7 M sulﬁte were added to a polarographic cell containing acetate buﬀer with a pH of about 4-5. The sulﬁte
concentration was taken to be 2.5 times larger than the stoichiometric amount according to our preliminary
studies. In order to accelerate the reaction by mixing, nitrogen gas was purged for 5, 10, 15, 20, and 30 min,
and polarograms were taken after each time interval.
As can be seen from Figure 4, when vitamin K 3 was added to sulﬁte ions, the sulﬁte peak height at
about -0.7 V decreased, and 3 new peaks, at -1.0, -1.2, and -1.45 V, were observed. These peaks belonged to
the H 2 Q formed from the reaction between sulﬁte and vitamin K 3 in Q form. The remaining sulﬁte quantity
after the reaction could be determined by standardized sulﬁte additions. The vitamin K 3 concentration, on the
other hand, was calculated using the stoichiometric relation given above in Eq. (1). It was found that under
these conditions, the reaction was not quantitative even when 30 min were given. However, when the solution
temperature was increased to 45 ◦ C, the reaction was quantitative within seconds. Thus, in all reactions
throughout the work, this temperature was used.
Determination of vitamin K 3 in a synthetic sample using indirect method
A synthetic sample containing 0.32 mL of 1 × 10 −3 M vitamin K 3 (Q) (3.2 × 10 −5 M in cell) was warmed to
45 ◦ C after the addition of 0.6 mL of 1.4 × 10 −3 M sulﬁte (8.4 × 10 −5 M in cell) and added to a polarographic
cell containing acetate buﬀer (pH = 4.5-5.5). The polarograms taken are shown in Figure 5. While the vitamin
K 3 (Q) peaks were observed at -1.0, -1.2, and -1.45 V, the sulﬁte peak appeared at about -0.7 V. The quantity of
sulﬁte that remained after the reaction with vitamin K 3 could be determined by the addition of standard 1.4 ×
10 −5 M sulﬁte. The vitamin K 3 (Q) concentration, on the other hand, was calculated from the stoichiometric
relation between sulﬁte and vitamin K 3 . Using this method, 3.2 × 10 −5 M vitamin K 3 (Q) could be determined
with high precision as (3.3 ± 0.5) × 10 −5 M for n = 4 and a 90% conﬁdence interval. The limit of quantiﬁcation
found was 2 × 10 −6 M with indirect determination using sulﬁte.
According to our former studies, 26 there will only be interference from cadmium, because of the peak
overlap with sulﬁte. However, this interference could be eliminated by the addition of EDTA, whereby the
cadmium peak shifts to more negative potentials because of the complex formation.
Direct determination of vitamin K 3 using its standard solution
Standardized vitamin K 3 solution (in Q form) can be used for direct determination in routine analysis with a
very simple and fast method, using the peak at about -1.0 V in acetate buﬀer (pH = 5.5).
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Figure 4. Investigation of the reaction between sulﬁte

Figure 5. Indirect determination of vitamin K 3 (Q) using

and vitamin K 3 (Q). a) pH = 5.5, 10 mL HAc-NaAc, b)

sulﬁte. a) pH = 5.5, 10 mL HAc-NaAc + 8.4 × 10 −5 M

−5
M vitamin
a + 8.4 × 10 −5 M SO 2−
3 , c) b + 3.2 × 10

+ 3.2 × 10 −5 M vitamin K 3 (Q) (warmed to about
SO 2−
3

K 3 (Q) + 5 min N 2 .

45

◦

C and cooled), b) a + 1.4 × 10 −5 M SO 2−
3 .

After the same oxidation process (section 2.2.5.) of the unknown sample, a DP polarogram was taken
in 0.1 M acetic acid (pH = 5.5) (Figure 6). Vitamin K 3 (Q) had 3 peaks, at -1.0, -1.2, and -1.45 V, in this
medium. From the peak at -1.0 V, the quantity of vitamin K 3 was calculated with standard additions using the
standardized solution of the vitamin K 3 prepared in section 2.2.5. Using this method, 7.9 × 10 −5 M vitamin
K 3 (quinine, Q) could be determined with high precision as (7.8 ± 0.7) × 10 −5 M for n = 4 and a 90%
conﬁdence interval.
Under the optimal conditions chosen, 0.1 M acetic acid with a pH of 5.5, the cathodic peak current at
-1.0 V was linearly proportional to vitamin K 3 concentrations from 5 × 10 −7 to 3 × 10 −5 M.
The linear regression equation was:
Ip /μA = 2.0 × 104 C + 0.0883(R2 = 0.998)(n = 4).

(4)

The LOD and limit of quantiﬁcation (LOQ) were obtained as 1.5 × 10 −7 and 5 × 10 −7 M, respectively,
according to the relation k× SD/ b , where k = 3 for the LOD and k = 10 for the LOQ, SD is the standard
deviation of the intercept, and b is the slope of the calibration curve. The high sensitivity of DPP is accompanied
by very good repeatability. This analytical performance was evaluated with 4 repeated measurements.
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Figure 6. Direct determination of unknown concentration of vitamin K 3 using standardized vitamin K 3 . a) pH = 5.5,
10 mL HAc-NaAc, b) a + 0.4 mL unknown vitamin K 3 sample, c) b + 9.92 × 10 −4 M vitamin K 3 solution.

Application to real samples using direct method
Direct determination of vitamin K 3 in clinical injection solution
The direct determination method was applied for vitamin K 3 in the clinical injection solution. The vitamin
K 3 obtained from the market (Libavit K) contained, according to the formula, 0.02 g of the vitamin in each 2
mL sample. From this, 10 mL of 10 −3 M solution was prepared, oxygen gas was passed for 20 min, and then
nitrogen gas was passed for about 20 min to expel oxygen from the solution. An aliquot of 0.1 mL was taken
and added to 10 mL of 0.1 M acetic acid (pH = 5.5) in a polarographic cell. From the peak at -1.0 V, the
quantity of vitamin K 3 was calculated with standard additions using the standardized solution of the vitamin.
The result found was 0.019 ± 0.005 g 2 mL −1 with a 90% conﬁdence interval (n = 4).
Determination of vitamin K 3 in blood serum
A blood serum (centrifuged) was taken from the medical center of Gazi University. For determination of the
vitamin K 3 in the serum, 0.5 mL of blood serum was added to a polarographic cell containing 9.0 mL of HAcNaAc electrolyte with a 5.5 pH, and a polarogram was taken. As can be seen from Figure 7, no peak for the
vitamin was observed, indicating that the level of K 3 was under the detection limit.
In order to demonstrate that vitamin K 3 in low concentrations can be determined in serum medium
accurately, a stock serum solution spiked with vitamin K 3 was used. For this purpose, 1.0 mL of blood serum
and 0.3 mL of 9.69 × 10 −4 M vitamin K 3 were mixed, such that the vitamin K 3 concentration was 2.23 ×
10 −4 M.
As can be seen from Figure 7, when 0.5 mL of serum sample spiked with vitamin K 3 was added to
a polarographic cell, a peak at -1.0 V appeared (curve b). The quantity of vitamin K 3 in this serum was
determined by standard additions (Figure 7, curve c), using the standardized solution of the vitamin prepared
as in section 2.2.5. The results obtained for the determination of spiked vitamin K 3 in blood serum samples
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are given in the Table. As can be seen there, high recoveries for vitamin K 3 were obtained by DPP for blood
serum samples.

200 nA

Peak Height

c

b

a

-0.2

-0.4

-0.6

-0.8

-1.0

-1.2

E(V) vs. SCE

Figure 7. Determination of vitamin K 3 in spiked blood serum, a) 9.0 mL 0.1 M HAc-NaAc electrolyte (pH = 5.5) +
0.5 mL blood serum, b) a + 0.5 mL stock serum solution spiked with vitamin K 3 (2.24 × 10 −4 M K 3 ) , c) b + 0.1 mL
9.69 × 10 −4 M K 3 (concentration was determined using standard sulﬁte).

Table. Determination of spiked vitamin K 3 in blood serum.
Sample

Spiked
vitamin K3 (M)

Blood serum

1.11 × 10−5

a

a

Found vitamin K3 (M)
√
X± ts/ N

Recovery
(%)

(1.09 ± 0.04) × 10−5

98

95% conﬁdence interval (n = 4)

These optimized procedures were also successfully applied for the determination of vitamin K 3 spiked
to serum. Recovery experiments were performed in order to evaluate the interference of organic and inorganic
components in blood serum. A calibration curve was obtained for vitamin K 3 in serum. The relationship
between peak current (I p ) and concentration of vitamin K 3 was rectilinear for the serum. Linear regression
analysis of the data gave the following equation:
Ip /μA = 1.1 × 104 C + 0.128(R2 = 0.999)(n = 4),

(5)
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where C is the concentration in mol L−1 and I is the peak current in μA. The LOD and LOQ were obtained as
3 × 10 −7 and 9 × 10 −7 M, respectively. The straight line had a slope of 1.1 × 10 −4 μA / mol L, an intercept
of 0.128 μA, and a correlation coeﬃcient of 0.999. The high sensitivity of DPP was accompanied by very good
repeatability.

Conclusions
The vitamin K 3 solutions on the market are only 95%-98% pure and very expensive. Thus, for direct
determination of the vitamin, a standard solution of vitamin has to be prepared using an indirect method.
In nearly no investigation mentioned above was this fact taken into account.
In this work, direct and indirect methods for the determination of vitamin K 3 were developed. For
indirect determination, the quantitative reaction between sulﬁte and vitamin K 3 (quinone form, Q) was used.
For this purpose, ﬁrst the optimum reaction conditions were investigated. It was found that at a pH of 4.5-5.5,
the reaction between the quinone (Q) form of the vitamin and sulﬁte was quantitative and very fast when the
temperature was 45 ◦ C. The sulﬁte concentration had to be at least 2.5 times that of the vitamin. A known
quantity of sulﬁte was added to an unknown vitamin K 3 (Q form) solution, and from the peak of sulﬁte at
about -0.7 V, the vitamin K 3 (Q) concentration was calculated. With this method, it was possible to prepare
a standard vitamin K 3 solution, and using this solution the vitamin content of the unknown solution could
be determined directly. The LOD for direct determination was 1.5 × 10 −7 , which was better than the LOD
obtained with the indirect method.
The DPP method presented for the quantitative determination of vitamin K 3 allowed accurate determination and was found to be rapid, simple, and highly sensitive. The main advantage of such a procedure is the
possibility of determining the concentration of the active component directly from the pharmaceuticals and natural samples without any previous treatment, such as extraction, clean-up, derivatization, or preconcentration,
which are tedious, time consuming, and polluting.
The proposed methods were successfully applied to the determination of vitamin K 3 in a clinical injection
solution and in blood serum. Contrary to modiﬁed electrodes, the results obtained in both methods are very
reproducible since, with the use of a dropping mercury electrode, the electrode surface is always new and the
behavior of the electrode is independent of its past history.
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25. Somer, G.; Koçak, A. Analyst 1993, 118, 657-659.
26. Yilmaz, U. T.; Somer, G. Anal. Chim. Acta 2007, 603, 30-35.
27. Brezina, M.; Zuman, P. Polarography in Medicine, Biochemistry and Pharmacy, New York, 1958.
28. Yilmaz, U. T.; Somer, G. J. Elec. Anal. Chem. 2008, 624, 59-63.

213

